Altimmune, Inc.·4

Feb 26, 6:47 PM ET

Lawver Teri L 4

4 · Altimmune, Inc. · Filed Feb 26, 2025

Insider Transaction Report

Form 4
Period: 2025-02-24
Transactions
  • Award

    Stock Options (option to buy)

    2025-02-24+69,80069,800 total
    Exercise: $6.11Exp: 2035-02-24Common Stock, par value $0.0001 (69,800 underlying)
Footnotes (1)
  • [F1]The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments following February 24, 2025 subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file
  • 4
    tm257585-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT